Systems Biology Reveals New Strategies for Personalizing Cancer Medicine and Confirms the Role of PTEN in Resistance to Trastuzumab
Dana Faratian(Western General Hospital), David J. Harrison(NHS Lothian)
Cited by 160
Related Papers
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
High-frequency developmental abnormalities in p53-deficient mice
|Current Biology|1995|467
Quantification of tumour budding, lymphatic vessel density and invasion through image analysis in colorectal cancer
|Journal of Translational Medicine|2014|53